Neurocritical Care News

Patients with concussion who underwent testing with eye-tracking technology had lower saccade performance, supporting the use of these tests to help guide rehabilitation for concussion, according to research in Optometry and Vision Science.

The FDA has granted 510(k) clearance for marketing of an ablation system that creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures, according to the manufacturer.

The investigational antidepressant ALTO-300 demonstrated clinically meaningful improvements in patients with major depressive disorder, particularly among those characterized by a biomarker, according to a manufacturer press release.

ORLANDO — Shipping medication and equipment to health care professionals for those with epilepsy in crisis zones such as Ukraine to allow for continuity of care requires a multidisciplinary effort, according to a speaker.

ORLANDO — Patients with seizures who were given point-of-care electroencephalography had shorter time to initiation and shorter hospital stays compared with those given conventional EEG, according to research.

ORLANDO — In cognitively healthy adults, the presence of seizures predicted earlier change from normal cognition to mild cognitive impairment but was not associated with change from MCI to dementia. according to research.

The FDA has cleared the use of a magnetic resonance spectroscopy platform to provide non-invasive measurement of brain chemistry and support diagnostic processes for a range of brain-related illnesses.

The FDA has cleared a traumatic brain injury blood test for commercial availability, paving the way for its distribution to hospitals in the United States.

A decrease of incidence and proportion of concussions resulted from implementation of a rule in the National Hockey League forbidding hits to the head, researchers reported in JAMA Network Open.

The FDA has issued a warning against the purchase or use of products that contain tianeptine, which has been illegally sold with claims to improve brain function and treat anxiety, depression, pain, opioid use disorder and other conditions.